Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Safer prescribing, older people/dementia
Safety in older patients/dementia
Schizoaffective disorder, atrial fibrillation patients
Schizophrenia and related psychoses
Schizophrenia treatment/prevention for tardive dyskinesia Omega-3 fatty acid (fish oils) in schizophrenia
Schizophrenia
Second-generation adverse effects classification diabetes, antipsychotic-related equivalent doses long-acting injectable antipsychotics maximum doses minimum effective doses
Second-generation antidepressants
second-generation antipsychotics (SGAs) 49
Second-generation antipsychotics - approximate equivalent doses
Second Opinion Appointed Doctor (SOAD), the Mental Health Act
Sedation alcohol effects management medication-induced over-sedation Relative adverse effects - a rough guide switching antipsychotics
Sedatives antihistamines not recommended for behavioural and psychological symptoms of dementia in pregnancy respiratory depression role in death from opioid agonists overdose use in patients with hepatic impairment
Sedatives in hepatic impairment
Seizures antiretrovirals drug risks for people withq11.2 deletion syndrome,820, 821-822 management psychotropic drug risks in people with epilepsy severe alcohol withdrawal
Selected clinical features and risks in people with 22q11.2 deletion syndrome.
selective oestrogen receptor modulators (SERMs)
Selective serotonin reuptake inhibitors Anxiety disorders in children and adolescents Depression in children and adolescents Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents
selective serotonin reuptake inhibitors (SSRIs) adverse effects relative to other antidepressants anxiety spectrum disorders arrhythmia risk atrial fibrillation patients bipolar depression bleeding risks gastrointestinal gynaecological and obstetric hemorrhage intracranial/intracerebral hemorrhage mechanisms post stroke depression risk factors surgical and postoperative
selective serotonin reuptake inhibitors (SSRIs) (contâ™d) cardiac effects gastrointestinal effects increased free plasma levels in hepatic impairment in pregnancy panic disorder platelet effects post stroke depression sexual dysfunction use in children and adolescents
Semaglutide, for antipsychotic-induced weight gain
Serotonergic antidepressants, treatment of sexual dysfunction
serotonin-noradrenaline reuptake inhibitors (SNRIs) anxiety spectrum disorders hyperprolactinaemia induction hyponatraemia induction in pregnancy pharmacokinetic drug interactions use in children and adolescents
Serotonin syndrome renal impairment switching antidepressants
Sertraline Alternatives to clozapine bulimia nervosa/binge eating disorder Equivalent doses in pregnancy Quick reference for licensed maximum doses Relative adverse effects - a rough guide use in patients with hepatic impairment
Severe alcohol dependence
Severe alcohol dependence: example of a fixed-dose chlordiazepoxide regimen
Severe alcohol withdrawal
Severity of Alcohol Dependence Questionnaire (SADQ) 480
Sexual adverse effects of antipsychotics